SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-038881
Filing Date
2020-03-26
Accepted
2020-03-26 17:01:50
Documents
1
Period of Report
2020-03-24

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4026
  Complete submission text file 0001104659-20-038881.txt   5305
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address
Korbel Gregory Alan (Reporting) CIK: 0001789032 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 20746798